3D 프린팅 의약품 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00010199
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 175
Buy Now

3D 프린팅 의약품 시장은 2019년 미화 2,852만 달러로 평가되었으며, 2020년부터 2027년까지 연평균 성장률(CAGR) 9.1%로 성장하여 2027년에는 미화 5,703만 달러에 이를 것으로 예상됩니다.

 

3D프린팅의약품은 3D프린팅 기술을 이용해 개인별로 맞춤 제작하여 보다 안전하고 효과적인 의약품을 말합니다. 이들 약물은 입안에서 쉽게 분산되는 단일 다공성 구조를 가지고 있기 때문에 고용량 약물을 그대로 삼킬 필요가 없습니다. 3D 프린팅 의약품의 주요 아이디어는 개인의 요구에 적합한 의약품을 설계하고 개발하는 것입니다. 글로벌 3D 프린팅 의약품 시장은 맞춤형 의약품 채택 증가와 같은 요인에 의해 주도됩니다. 또한 연구 개발 활동의 증가와 삼킴곤란의 유병률 증가도 예측 기간 동안 3D 시장 성장을 주도할 것으로 예상됩니다. 그러나 불법 약물 개발을 위해 3D 프린팅을 활용하는 것은 시장 성장을 억제합니다. 의료 인프라 개발 및 의약품 분야의 3D 프린팅에 대한 인식 제고  시장 성장을 위한 수익성 있는 기회를 창출합니다.

수익성이 높은 지역 3D 프린팅 의약품 시장



시장 통찰력

h3>

맞춤형 약물 채택 증가

맞춤형 약물은 특정 약물 전달 및 용량에 의존하는 치료 분야가 성장하고 있는 분야입니다. PMC가 발표한 연구에 따르면 맞춤형 의약품은 2005년 FDA가 승인한 새로운 분자 실체의 5%만을 차지했습니다. 반면 2016년에는 25% 이상을 차지했습니다. 또한 파이프라인에 있는 모든 화합물의 42%와 종양학 화합물의 73%가 맞춤형 의약품이 될 가능성이 있습니다. 더욱이, 바이오제약 기업들은 지난 5년간 맞춤형 의약품에 대한 R&D 투자를 거의 두 배로 늘렸고, 향후 5년간 투자를 33% 늘릴 것으로 예상하고 있습니다. 또한 생물약학 연구자들은 향후 5년 동안 개발 중인 맞춤형 의약품의 수가 69% 증가할 것으로 예측합니다.

3D 프린팅은 자동화된 제어를 통해 맞춤형 의약품 시스템을 만들 수 있는 가능성을 제공합니다. 약물 용량은 낮은 약물 농도와 높은 약물 농도 모두에 적합합니다. 이러한 장점을 통해 제약회사는 효능과 순응도를 높일 수 있을 뿐만 아니라 다른 제형으로 시장 점유율을 확대하고 확보함으로써 브랜드 수명에 기여할 수 있습니다. 이 획기적인 제조 방법과 빠른 용융 기능을 통해 여러 장애물을 극복하고 고형분 투여 시장에서 더 나은 환자 결과에 기여할 수 있습니다. 예를 들어, FabRx Ltd.는 희귀한 대사 질환이 있는 어린이를 치료하기 위해 맞춤형 3D 프린팅 제형을 사용하는 독점 Printlets 기술을 사용하여 세계 최초의 인간 내 임상 연구를 완료했습니다. 또한, 같은 회사는 2020년 4월에 맞춤형 의약품 제조를 위한 최초의 제약용 3D 프린터인 M3DIMAKER를 출시했습니다. 따라서 맞춤형 의약품을 준비하기 위한 새로운 제조 시스템이 필요하며, 희귀 질환에 대한 3D 프린팅의 잠재적인 적용은 다음과 같습니다. 셀 수 없는. 이는 어린이에게 약을 더욱 안전하고 매력적으로 만들어 3D 프린팅 약품 시장의 성장을 촉진할 수 있습니다.

Dosage Form-BasedInsights

복용량을 기준으로 3D 프린팅 의약품 시장은 정제, 캡슐, 다중 약물 임플란트, 나노입자, 용액 및 기타 복용 형태로 분류됩니다. 2019년에는 태블릿 부문이 시장에서 가장 큰 점유율을 차지했으며, 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 현재 3D 프린팅 약품은 시중에서 알약 형태로만 판매되고 있습니다. 그러나 다른 제형도 향후 몇 년 안에 상용화될 가능성이 높습니다.

제형별 3D 프린팅 의약품 시장– 2019년 및 2027년


기술 기반 통찰력

기술을 기반으로 3D 프린팅 의약품 시장은 다음과 같이 분류됩니다. 잉크젯 인쇄, 직접 기록, 우편 투여량, 열 잉크젯 인쇄, 융합 증착 모델링, 분말 베드 인쇄, 광조형(SLA) 및 반고체 압출(SSE). 우편 복용량 기술 부문은 시장에서 가장 큰 점유율을 차지했습니다. 또한 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

전략적 통찰력

제품 출시 및 FDA 승인은 기업이 전 세계적으로 입지를 확장하고 전략이 허용하는 한 증가하는 수요를 충족하기 위해 일반적으로 채택하는 전략입니다.

3D 프린팅 의약품 시장 참여자들은 브랜드 이름을 유지하는 동시에 글로벌 고객 기반을 확대할 수 있는 협업 전략도 채택했습니다.

  ;

3D 프린팅 의약품 시장 – 제형별

  • 정제
  • 캡슐
  • 다중 약물 임플란트
  • 나노입자
  • 솔루션
  • li>
  • 기타

3D 프린팅 의약품 시장 – 기술별

  • 잉크젯 인쇄
  • 직접 기록
  • Zip Dose
  • 열전사 잉크젯 인쇄
  • 융합 증착 모델링
  • 파우더 베드 프린팅
  • 광 조형(SLA)
  • 반고체 압출(SSE)

3D 프린팅 의약품 시장&ndash ; 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • < li>유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 스페인
    • 나머지 유럽
  • 아시아 태평양
    • 중국
    • 인도
    • 대한민국
    • 일본
    • 호주
    • 아시아 태평양 지역
  • 중동 및 아프리카
    • 남아프리카
    • 사우디아라비아
    • UAE
    • 중동 및 아프리카 나머지 지역
  • 남아메리카
    • 브라질
    • 아르헨티나
    • 남아메리카 나머지 지역

회사 프로필

  • APRECIA PHARMACEUTICALS, LLC
  • FabRx LTD
  • Cycle Pharmaceuticals
  • GLAXOSMITHKLINE PLC.
  • ASTRAZENECA
  • 트바스타
  • 머크 KGGA
  • 테루모 코퍼레이션
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is 3D Printed Drug?

3D Printed Drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact.

What are the driving factors for the 3D printed drugs market across the globe?

Increasing awareness of benefits offered by 3D printed drugs and growing emphasis on personalized medicines

Who are the major players in the 3D printing drugs market?

Aprecia Pharmaceuticals, LLC and FabRx LTD are the major players in the market.

The List of Companies - 3D Printed Drugs Market

  1. APRECIA PHARMACEUTICALS, LLC
  2. FabRx LTD
  3. Cycle Pharmaceuticals
  4. GLAXOSMITHKLINE PLC.
  5. ASTRAZENECA
  6. Tvasta
  7. Merck KGGA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports